OCTREOSCAN
Diagnostic - For Intravenous Use.
Approved
Approval ID
93d8f3b2-1216-41dc-a63d-0e812b33891d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 21, 2022
Manufacturers
FDA
Curium US LLC
DUNS: 079875617
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Indium In -111 Pentetreotide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code69945-050
Application NumberNDA020314
Product Classification
M
Marketing Category
C73594
G
Generic Name
Indium In -111 Pentetreotide
Product Specifications
Effective DateDecember 22, 2021
FDA Product Classification